Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non ‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D)

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - June 25, 2018 Category: Endocrinology Authors: Patrick B. Ryan PhD , John B. Buse MD , Martijn J. Schuemie PhD , Frank DeFalco BA , Zhong Yuan MD, PhD , Paul E. Stang PhD , Jesse A. Berlin ScD , Norman Rosenthal MD Source Type: research